DSIJ Mindshare

This Multibagger Pharma Giant’s Subsidiary Becomes First Fully NABL Accredited Company, Bags 2 Prestigious Awards for Diagnostic Excellence

Over the past year, the stock has delivered a return of 27.39 per cent, while the three-year return is 171.38 per cent.

DSIJ Intelligence-2 0 387 Article rating: 4.3

Over the past year, the stock has delivered a return of 27.39 per cent, while the three-year return is 171.38 per cent.

Pharma Major Shares Rebound from Lows; Firm Reports 39.5 per cent Profit Growth

The company reported a net income of Rs 8,552 crore, marking a 39.5 per cent YoY growth. Total sales increased 10.6 per cent YoY to Rs 56,186 crore from Rs 50,799 crore in Q3 FY24

DSIJ Intelligence 0 256 Article rating: 5.0

The company reported a net income of Rs 8,552 crore, marking a 39.5 per cent YoY growth. Total sales increased 10.6 per cent YoY to Rs 56,186 crore from Rs 50,799 crore in Q3 FY24

This pharma company stock went 8 per cent high, do you own it?

With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore.

DSIJ Intelligence-1 0 1430 Article rating: 5.0

This pharma company stock went 8 per cent high, do you own it?                                                                                                                                                                                                       With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore.

A Volatile End: Nifty closes below 18,200 amid volatility; Realty, Pharma and metals take a hit

Nifty PSU Bank (+3.93 per cent) emerged as the top performers amongst the sectoral indices.  

DSIJ Intelligence 0 991 Article rating: 3.5

NSE Nifty 50 index plunged 0.25 per cent to close below 18,200 level while Sensex slipped 150 points. Nifty Midcap and Nifty Smallcap closed lower by 0.74 per cent and 0.56 per cent respectively.

RSS
123
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR